Abbott Labs Stock-Based Compensation — Historical Data
Abbott Labs (ABT) stock-based compensation was $664M in FY2025 (-1% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$664M
-1%
2024
$673M
+5%
2023
$644M
-6%
2022
$685M
+7%
2021
$640M
+17%
2020
$546M
+5%
2019
$519M
+9%
2018
$477M
+17%
2017
$406M
+31%
2016
$310M
+6%
2015
$292M
+19%
2014
$246M
-6%
2013
$262M
-39%
2012
$433M
+13%
2011
$383M
-1%
2010
$385M
+5%
2009
$365M
+4%
2008
$350M
-19%
2007
$430M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q1 2026
$317M
Q4 2025
$113M
Q3 2025
$120M
Q2 2025
$142M
Q1 2025
$289M
Q4 2024
$111M
Q3 2024
$117M
Q2 2024
$141M
Q1 2024
$304M
Q4 2023
$114M
Q3 2023
$117M
Q2 2023
$132M
Source: ABT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.